These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24612767)

  • 21. Molecular modeling of the additional inhibitor site located in secretory phospholipase A(2).
    Ompraba G; Velmurugan D; Louis PA; Rafi ZA
    J Biomol Struct Dyn; 2010 Feb; 27(4):489-500. PubMed ID: 19916570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes.
    Rosenson RS
    Curr Opin Lipidol; 2010 Dec; 21(6):473-80. PubMed ID: 20739882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2.
    Pereañez JA; Patiño AC; Núñez V; Osorio E
    Chem Biol Interact; 2014 Sep; 220():94-101. PubMed ID: 24995575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.
    Bovens S; Schulze Elfringhoff A; Kaptur M; Reinhardt D; Schäfers M; Lehr M
    J Med Chem; 2010 Dec; 53(23):8298-308. PubMed ID: 21067218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of platinum and ruthenium coordination complexes with pancreatic phospholipase A(2) and phospholipids investigated by MALDI TOF mass spectrometry.
    Kamčeva T; Radisavljević M; Vukićević I; Arnhold J; Petković M
    Chem Biodivers; 2013 Nov; 10(11):1972-86. PubMed ID: 24243606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel inhibitors of Daboia russelli phospholipase A2 using the combined pharmacophore modeling approach.
    Ramakrishnan C; Joshi V; Joseph JM; Vishwanath BS; Velmurugan D
    Chem Biol Drug Des; 2014 Oct; 84(4):379-92. PubMed ID: 24703201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prenatal steroidal inhibition of sPLA2 in a rat model of preterm lung.
    Remesal A; De Luca D; San Feliciano L; Isidoro-Garcia M; Minucci A; Pocino K; Casas J; Fabrias G; Capoluongo ED; de la Cruz DL
    Pulm Pharmacol Ther; 2016 Feb; 36():31-6. PubMed ID: 26704083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Silico and In Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2).
    Mohamed Tap F; Abd Majid FA; Ismail HF; Wong TS; Shameli K; Miyake M; Ahmad Khairudin NB
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29351216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
    Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
    Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A facile assay to monitor secretory phospholipase A₂ using 8-anilino-1-naphthalenesulfonic acid.
    Vivek HK; Swamy SG; Priya BS; Sethi G; Rangappa KS; Swamy SN
    Anal Biochem; 2014 Sep; 461():27-35. PubMed ID: 24915638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indole-5-phenylcarbamate derivatives as human non-pancreatic secretory phospholipase A2 inhibitor.
    Liu Y; Han XF; Huang CK; Hao X; Lai LH
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4540-2. PubMed ID: 16105733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents.
    Soubhye J; van Antwerpen P; Dufrasne F
    Curr Med Chem; 2018; 25(21):2418-2447. PubMed ID: 29345571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of a trehalose lipid biosurfactant produced by Rhodococcus erythropolis 51T7 with a secretory phospholipase A2.
    Zaragoza A; Teruel JA; Aranda FJ; Ortiz A
    J Colloid Interface Sci; 2013 Oct; 408():132-7. PubMed ID: 23948458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin as an inhibitor of snake venom secretory phospholipase A2.
    Cotrim CA; de Oliveira SC; Diz Filho EB; Fonseca FV; Baldissera L; Antunes E; Ximenes RM; Monteiro HS; Rabello MM; Hernandes MZ; de Oliveira Toyama D; Toyama MH
    Chem Biol Interact; 2011 Jan; 189(1-2):9-16. PubMed ID: 21056032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents.
    Pedada SR; Yarla NS; Tambade PJ; Dhananjaya BL; Bishayee A; Arunasree KM; Philip GH; Dharmapuri G; Aliev G; Putta S; Rangaiah G
    Eur J Med Chem; 2016 Apr; 112():289-297. PubMed ID: 26907155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.
    Thwin MM; Satyanarayanajois SD; Nagarajarao LM; Sato K; Arjunan P; Ramapatna SL; Kumar PV; Gopalakrishnakone P
    J Med Chem; 2007 Nov; 50(24):5938-50. PubMed ID: 17973469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of phospholipase A
    Kokotou MG; Limnios D; Nikolaou A; Psarra A; Kokotos G
    Expert Opin Ther Pat; 2017 Feb; 27(2):217-225. PubMed ID: 27718763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailoring the pH dependence of human non-pancreatic secretory phospholipase A2 by engineering surface charges.
    Qiu S; Lai L
    Appl Biochem Biotechnol; 2013 Nov; 171(6):1454-64. PubMed ID: 23955349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease.
    Rosenson RS; Elliott M; Stasiv Y; Hislop C;
    Eur Heart J; 2011 Apr; 32(8):999-1005. PubMed ID: 21081550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactadherin inhibits secretory phospholipase A2 activity on pre-apoptotic leukemia cells.
    Nyegaard S; Novakovic VA; Rasmussen JT; Gilbert GE
    PLoS One; 2013; 8(10):e77143. PubMed ID: 24194865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.